%0 Journal Article
%T Identification and Rescue of Splice Defects Caused by Two Neighboring Deep-Intronic ABCA4 Mutations Underlying Stargardt Disease
%A Alejandro Garanto
%A Carel B. Hoyng
%A Jana Zernant
%A Mubeen Khan
%A Nathalie M. Bax
%A Rando Allikmets
%A Riccardo Sangermano
%A Rob W.J. Collin
%A Silvia Albert
%A Winston Lee
%J Archive of "American Journal of Human Genetics".
%D 2018
%R 10.1016/j.ajhg.2018.02.008
%X Sequence analysis of the coding regions and splice site sequences in inherited retinal diseases is not able to uncover ¡«40% of the causal variants. Whole-genome sequencing can identify most of the non-coding variants, but their interpretation is still very challenging, in particular when the relevant gene is expressed in a tissue-specific manner. Deep-intronic variants in ABCA4 have been associated with autosomal-recessive Stargardt disease (STGD1), but the exact pathogenic mechanism is unknown. By generating photoreceptor precursor cells (PPCs) from fibroblasts obtained from individuals with STGD1, we demonstrated that two neighboring deep-intronic ABCA4 variants (c.4539+2001G>A and c.4539+2028C>T) result in a retina-specific 345-nt pseudoexon insertion (predicted protein change: p.Arg1514Leufs£¿36), likely due to the creation of exonic enhancers. Administration of antisense oligonucleotides (AONs) targeting the 345-nt pseudoexon can significantly rescue the splicing defect observed in PPCs of two individuals with these mutations. Intriguingly, an AON that is complementary to c.4539+2001G>A rescued the splicing defect only in PPCs derived from an individual with STGD1 with this but not the other mutation, demonstrating the high specificity of AONs. In addition, a single AON molecule rescued splicing defects associated with different neighboring mutations, thereby providing new strategies for the treatment of persons with STGD1. As many genes associated with human genetic conditions are expressed in specific tissues and pre-mRNA splicing may also rely on organ-specific factors, our approach to investigate and treat splicing variants using differentiated cells derived from individuals with STGD1 can be applied to any tissue of interest
%K Stargardt disease
%K ABCA4
%K deep-intronic mutation
%K pseudoexon
%K splicing modulation
%K induced pluripotent stem cells
%K photoreceptor precursor cells
%K exonic splicing enhancer
%K antisense oligonucleotide
%K nonsense-mediated decay
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985352/